Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Updated results from a phase I trial of CAR-T cell therapy for r/rMM

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Updated results from a phase I trial of CAR-T cell therapy for r/rMM ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018

Fatigue at baseline predicts shorter survival in older patients with a haematological malignancy

Prof Reinhard Stauder - University of Innsbruck, Innsbruck, Austria
Fatigue at baseline predicts shorter survival in older patients with a haematological malignancy ( Prof Reinhard Stauder - University of Innsbruck, Innsbruck, Austria )
15 Jun 2018

Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma

Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018

Updates from Myeloma XI trial

Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK
Updates from Myeloma XI trial ( Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK )
15 Jun 2018

Ribosomal lesions promote oncogenic mutagenesis

Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium
Ribosomal lesions promote oncogenic mutagenesis ( Dr Sergey Sulima - Katholieke Universiteit Leuven, Lueven, Belgium )
15 Jun 2018

Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma

Dr Francesca Gay - University of Torino, Torino, Italy
Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
15 Jun 2018

Interim results of RELEVANCE trial in follicular lymphoma

Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Interim results of RELEVANCE trial in follicular lymphoma ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

Disease control in advanced Hodgkin lymphoma

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018

Improved OS with obinutuzumab in the CLL11 study

Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Improved OS with obinutuzumab in the CLL11 study ( Dr Valentin Goede  - St. Marien-Hospital, Cologne, Germany )
15 Jun 2018

Rituximab in combination therapies for FL: Interim results

Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018

Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018

Mapping 3D genome dynamics in B cells

Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain
Mapping 3D genome dynamics in B cells ( Dr José Ignacio Martin-Subero - University of Barcelona, Barcelona, Spain )
15 Jun 2018